Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "LEUKEMIA & LYMPHOMA"

Add to list
- Conference Paper
- C3
Ibrutinib for first-line treatment of chronic lymphocytic leukemia in patients aged >= 65 year of age : results with 5 years of follow-up for the RESONATE-2 study

Alessandra Tedeschi, Jan A. Burger, Paul Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen, Steven Coutre, Stephen Devereux, et al.

(2020) LEUKEMIA & LYMPHOMA. 61(Suppl 1). p.38-40
Add to list
Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies

Xavier Mignard, Lucie Biard, Virginie Lemiale, Djamel Mokart, Frédéric Pène, Achille Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, et al.

(2019) LEUKEMIA & LYMPHOMA. 60(5). p.1156-1163
Add to list
Determinants of 1-year survival in critically ill acute leukemia patients : a GRRR-OH study

Márcio Tavares, Virginie Lemiale, Djamel Mokart, Frédéric Pène, Etienne Lengliné, Achille Kouatchet, Julien Mayaux, François Vincent, Martine Nyunga, Fabrice Bruneel, et al.

(2018) LEUKEMIA & LYMPHOMA. 59(6). p.1323-1331
Add to list
Delayed elemination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population

Tieneke Bauters (UGent) , Tim Lammens (UGent) , Pauline Belin, Yves Benoit (UGent) , Hugo Robays (UGent) and Barbara De Moerloose (UGent)

(2013) LEUKEMIA & LYMPHOMA. 54(5). p.1094-1096
Add to list
- Conference Paper
- C3
Deguelin, a PI3K/Akt inhibitor induceds apoptotic killing of B-CLL cells in vitro

Ben Geeraerts, Fritz Offner (UGent) and Dieter Deforce (UGent)

(2005) Leukemia & Lymphoma. 46(suppl. 1).
Add to list
- Conference Paper
- C3
Differential proteome analysis of Chronic lymphocytic leukemia subtypes

Ben Geeraerts, Aline Dhondt, Dirk Elewaut (UGent) , Jan Van Bocxlaer (UGent) and Dieter Deforce (UGent)

(2005) Leukemia & Lymphoma. 46(suppl. 1).
Add to list
- Journal Article
- A1
Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia

Katrien Swerts (UGent) , Barbara De Moerloose (UGent) , Catharina Dhooge (UGent) , Lucien Noens (UGent) , Genevieve Laureys (UGent) , Yves Benoit (UGent) and Jan Philippé (UGent)

(2004) LEUKEMIA & LYMPHOMA. 45(11). p.2221-2228
Add to list
- Journal Article
- A1
Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries

Lieven Annemans (UGent) , K MOEREMANS, M LAMOTTE, JG CONDE, H VAN DEN BERG, H MYINT, R PIETERS and A UYTTEBROECK

(2003) LEUKEMIA & LYMPHOMA. 44(1). p.77-83
Add to list
- Conference Paper
- C3
The protein expression pattern of CLL cells is stable over six months intervals

Ben Geeraerts, Jan Van Bocxlaer (UGent) , Willy Lambert (UGent) , Carlos Van Peteghem (UGent) , Dieter Deforce (UGent) and Dirk Elewaut (UGent)

(2003) Leukemia & Lymphoma. 44(suppl. 2).
Add to list
Extramedullary plasmacytoma of the cavernous sinus

I Vande Broek, T Stadnik, Alfred Meurs (UGent) , J Maes, B Van Camp and R Schots

(2002) LEUKEMIA & LYMPHOMA. 43(8). p.1691-1693

Academic Bibliography

Ibrutinib for first-line treatment of chronic lymphocytic leukemia in patients aged >= 65 year of age : results with 5 years of follow-up for the RESONATE-2 study

Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies

Determinants of 1-year survival in critically ill acute leukemia patients : a GRRR-OH study

Delayed elemination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population

Deguelin, a PI3K/Akt inhibitor induceds apoptotic killing of B-CLL cells in vitro

Differential proteome analysis of Chronic lymphocytic leukemia subtypes

Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia

Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries

The protein expression pattern of CLL cells is stable over six months intervals

Extramedullary plasmacytoma of the cavernous sinus

Contents

Support

Contact